Transplantation Immunology Unit and National Reference Laboratory for Histocompatibility, Geneva University Hospitals, Geneva, Switzerland.
Front Immunol. 2021 Jan 20;11:588741. doi: 10.3389/fimmu.2020.588741. eCollection 2020.
In transplantation, direct allorecognition is a complex interplay between T-cell receptors (TCR) and HLA molecules and their bound peptides expressed on antigen-presenting cells. In analogy to HLA mismatched hematopoietic stem cell transplantation (HSCT), the TCR CDR3β repertoires of alloreactive cytotoxic CD8 responder T cells, defined by the cell surface expression of CD137 and triggered by HLA mismatched stimulating cells, were analyzed in different HLA class I mismatched combinations. The same HLA mismatched stimulatory cells induced very different repertoires in distinct but HLA identical responders. Likewise, stimulator cells derived from HLA identical donors activated CD8 cells expressing very different repertoires in the same mismatched responder. To mimic inflammation, expression of HLA class l antigens was upregulated on stimulating cells by the inflammatory cytokines TNFα and IFNβ. The repertoires differed whether the same responder cells were stimulated with cells treated or not with both cytokines. In conclusion, the selection and expansion of alloreactive cytotoxic T-cell clonotypes expressing a very diverse repertoire is observed repeatedly despite controlling for HLA disparities and is significantly influenced by the inflammatory status. This makes prediction of alloreactive T-cell repertoires a major challenge in HLA mismatched HSCT.
在移植中,直接同种异体识别是 T 细胞受体 (TCR) 与 HLA 分子及其在抗原呈递细胞上表达的结合肽之间的复杂相互作用。类似于 HLA 错配造血干细胞移植 (HSCT),通过 CD137 表面表达和 HLA 错配刺激细胞触发,分析了同种异体反应性细胞毒性 CD8 应答 T 细胞的 TCR CDR3β 库,这些 T 细胞是由 HLA 错配刺激细胞定义的。在不同的 HLA Ⅰ类错配组合中,相同的 HLA 错配刺激细胞在不同但 HLA 相同的应答者中诱导非常不同的库。同样,来自 HLA 相同供体的刺激细胞在相同的错配应答者中激活表达非常不同库的 CD8 细胞。为了模拟炎症,通过炎症细胞因子 TNFα 和 IFNβ 上调刺激细胞上 HLA Ⅰ类抗原的表达。无论用还是不用两种细胞因子处理刺激细胞,相同的应答细胞被刺激时,库都会发生变化。总之,尽管控制了 HLA 差异,但仍观察到表达非常多样化库的同种异体反应性细胞毒性 T 细胞克隆型的选择和扩增,并且炎症状态的影响显著。这使得预测 HLA 错配 HSCT 中的同种异体反应性 T 细胞库成为一个主要挑战。